新的曼扎胺类化合物具有强大的抗传染病活性
K A El Sayed1, M Kelly, U A Kara
1Department of Pharmacognosy, NCDNP, University of Mississippi, University, MS, USA.
Journal of the American Chemical Society
|July 18, 2001
概括
新的曼扎明化合物,包括新卡卢,从印度-太平洋海绵中分离出来. 这些化合物作为抗疟疾和抗感染剂显著有前途,性能优于目前的治疗方法.
科学领域:
- 海洋天然产品 化学 化学
- 药物发现 药物发现 药物发现
- 化学分类学 化学分类学
背景情况:
- 曼胺类化合物是一种因其生物活性而闻名的海洋天然产品.
- 以前的研究已经确定了海绵中的各种曼扎明衍生物,突出了它们的治疗潜力.
- 海洋海绵中的化学多样性继续产生新的生物活性化合物.
研究的目的:
- 从未被描述的海绵属中分离和鉴定新的曼扎明酶体和新型曼扎明二聚体.
- 为了阐明新发现的化合物的相对立体化学.
- 评估分离化合物的体外和体内生物活性,特别是它们的抗疟疾和抗感染性质.
主要方法:
- 使用色谱技术分离和净化二次代谢产物.
- 通过光谱方法 (NMR,MS) 和NOE相关性阐明结构.
- 用于立体化学分析的分子建模.
- 在体外和体内测试以评估抗疟疾和抗感染活性.
主要成果:
- 隔离了8-氧曼胺A和曼胺F的新反体.
- 新可鲁胺的特征,一种新型的曼扎明二聚物,具有既定的相对立体化学.
- 在体内表现出优越的抗疟疾活性,与素和氨酸相比.
- 在体外对结核病和毒素菌有显著的活性.
结论:
- 这种未经描述的印太海绵属是结构新和生物活跃的manzamine类化合物的丰富来源.
- 新可卢胺和其他分离的曼扎胺为开发新的抗疟疾和抗感染药物提供了有前途的线索.
- 需要对这些化合物的化学和生物特性进行进一步的研究.
相关概念视频
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...